Lipoprotein profile changes in children after renal transplantation in the modern immunosuppression era

Pediatric Transplantation

Volumn 12, Issue 7, 2008, Pages 796-803

  Sgambat, Kristen ^a   He, Jianping ^a   McCarter, Robert J ^a   Moudgil, Asha ^a  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

Dyslipidemia; Kidney transplantation; Pediatric; Statins

Indexed keywords

ATORVASTATIN; AZATHIOPRINE; DACLIZUMAB; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ADULT; AGE; ARTICLE; BODY MASS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DRUG DOSE INCREASE; DYSLIPIDEMIA; ETHNICITY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; SEX;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; HEPTANOIC ACIDS; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; LIPOPROTEINS; MALE; PREDNISOLONE; PREVALENCE; PYRROLES;

EID: 53849099632     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2008.00905.x     Document Type: Article

References (50)

1. Lindholm A, Albrechtsen D, Frodin L, Tufveson G, Persson NH, Lundgren G. Ischemic heart disease - Major cause of death and graft loss after renal transplantation in Scandinavia. Transplantation 1995 : 60 : 451 457.
2. Silverstein DM. Risk factors for cardiovascular disease in pediatric renal transplant recipients. Pediatr Transplant 2004 : 8 : 386 393.
3. Groothoff JW. Long-term outcomes of children with end-stage renal disease. Pediatr Nephrol 2005 : 20 : 849 853.
4. U.S. Renal Data System. USRDS 2006 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Diseases. Bethesda, MD, 2006.
5. Sundstrom J, Lind L, Vessby B, Andren B, Aro A, Lithell H. Dyslipidemia and an unfavorable fatty acid profile predict left ventricular hypertrophy 20 years later. Circulation 2001 : 103 : 836 841.
6. Ponticelli C, Villa M, Cesana B, Montagnino G, Tarantino A. Risk factors for late kidney allograft failure. Kidney Int 2002 : 62 : 1848 1854.
7. Pascual M, Theruvath T, Kawai T, Tolkoff-Rubin N, Cosimi AB. Strategies to improve long-term outcomes after renal transplantation. N Engl J Med 2002 : 346 : 580 590.
8. Kasiske BL, Chakkera HA, Roel J. Explained and unexplained ischemic heart disease risk after renal transplantation. J Am Soc Nephrol 2000 : 11 : 1735 1743.
9. Guijarro C, Massy ZA, Kasiske BL. Clinical correlation between renal allograft failure and hyperlipidemia. Kidney Int Suppl 1995 : 52 : S56 S59.
10. Massy ZA, Guijarro C, Wiederkehr MR, Ma JZ, Kasiske BL. Chronic renal allograft rejection: Immunologic and nonimmunologic risk factors. Kidney Int 1996 : 49 : 518 524.
11. Del Castillo D, Cruzado JM, Manel Diaz J, et al. The effects of hyperlipidaemia on graft and patient outcome in renal transplantation. Nephrol Dial Transplant 2004 : 19 (Suppl. 3 67 71.
12. Massy ZA. Hyperlipidemia and cardiovascular disease after organ transplantation. Transplantation 2001 : 72 : S13 S15.
13. Kasiske BL. Epidemiology of cardiovascular disease after renal transplantation. Transplantation 2001 : 72 : S5 S8.
14. Sharma AK, Myers TA, Hunninghake DB, Matas AJ, Kashtan CE. Hyperlipidemia in long-term survivors of pediatric renal transplantation. Clin Transplant 1994 : 8 : 252 257.
15. Silverstein DM, Palmer J, Polinsky MS, Braas C, Conley SB, Baluarte HJ. Risk factors for hyperlipidemia in long-term pediatric renal transplant recipients. Pediatr Nephrol 2000 : 14 : 105 110.
16. Chavers BM, Hardstedt M, Ginningham KJ. Hyperlipidemia in pediatric kidney transplant recipients treated with cyclosporine. Pediatr Nephrol 2003 : 18 : 565 569.
17. Goldstein S, Duhamel G, Laudat MH, et al. Plasma lipids, lipoproteins and apolipoproteins AI, AII, and B in renal transplanted children: What risk for accelerated atherosclerosis? Nephron 1984 : 38 : 87 92.
18. Milliner DS, Morgenstern BZ, Murphy M, Gonyea J, Sterioff S. Lipid levels following renal transplantation in pediatric recipients. Transplant Proc 1994 : 26 : 112 114.
19. Querfeld U, Lang M, Friedrich JB, Kohl B, Fiehn W, Scharer K. Lipoprotein(a) serum levels and apolipoprotein(a) phenotypes in children with chronic renal disease. Pediatr Res 1993 : 34 : 772 776.
20. Singh A, Tejani C, Benfield M, Tejani A. Sequential analysis of the lipid profile of children post-renal transplantation. Pediatr Transplant 1998 : 2 : 216 223.
21. Ibels LS, Alfrey AC, Weil R 3rd. Hyperlipidemia in adult, pediatric and diabetic renal transplant recipients. Am J Med 1978 : 64 : 634 642.
22. Saldanha LF, Hurst KS, Amend WJ JR., et al. Hyperlipidemia after renal transplantation in children. Am J Dis Child 1976 : 130 : 951 953.
23. Lowry RP, Soltys G, Peters L, Mangel R, Sniderman AD. Type II hyperlipoproteinemia, hyperapobetalipoproteinemia, and hyperalphalipoproteinemia following renal transplantation: Implications for atherogenic risk. Transplant Proc 1987 : 19 : 3426 3430.
24. Bittar AE, Ratcliffe PJ, Richardson AJ, et al. The prevalence of hyperlipidemia in renal transplant recipients. Associations with immunosuppressive and antihypertensive therapy. Transplantation 1990 : 50 : 987 992.
25. Marubayashi S, Ohdan H, Tashiro H, et al. Studies on post-transplant dyslipidemia in kidney transplant patients. Hiroshima J Med Sci 2005 : 54 : 39 45.
26. Satterthwaite R, Aswad S, Sunga V, et al. Incidence of new-onset hypercholesterolemia in renal transplant patients treated with FK506 or cyclosporine. Transplantation 1998 : 65 : 446 449.
27. Morales JM, Dominguez-Gil B. Impact of tacrolimus and mycophenolate mofetil combination on cardiovascular risk profile after kidney transplantation. J Am Soc Nephrol 2006 : 17 : S296 S303.
28. Ochiai T, Ishibashi M, Fukao K, et al. Japanese multicenter studies of FK 506 in renal transplantation. Japanese FK 506 Study Group. Transplant Proc 1995 : 27 : 50 53.
29. Neylan JF. Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine. FK506 Kidney Transplant Study Group. Transplantation 1998 : 65 : 515 523.
30. Kim HC, Hwang EA, Han SY, Park SB, Kim HT, Cho WH. Primary immunosuppression with tacrolimus in kidney transplantation: Three-year follow-up in a single center. Transplant Proc 2004 : 36 : 2082 2083.
31. Mayer AD, Dmitrewski J, Squifflet JP, et al. Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: A report of the European Tacrolimus Multicenter Renal Study Group. Transplantation 1997 : 64 : 436 443.
32. Pennisi AJ, Heuser ET, Mickey MR, Lipsey A, Malekzadeh MH, Fine RN. Hyperlipidemia in pediatric hemodialysis and renal transplant patients. Associated with coronary artery disease. Am J Dis Child 1976 : 130 : 957 961.
33. Gidding SS, Dennison BA, Birch LL, et al. Dietary recommendations for children and adolescents: A guide for practitioners: Consensus statement from the American Heart Association. Circulation 2005 : 112 : 2061 2075.
34. National Center for Health Statistics. 2000 CDC growth charts: United States. In : http://www.cdc.gov/growthcharts, accessed on March 21, 2007.
35. Phillips S, Edlbeck A, Midge K, Goday P. Ideal body weight in children. Nutr Clin Pract 2007 : 22 : 240 245.
36. Waterlow JC. Classification and definition of protein-calorie malnutrition. BMJ 1972 : 3 : 566 569.
37. Muller T, Kosppe S, Arbeiter K, et al. Serum lipid pattern unifies following renal transplantation in children. Pediatr Nephrol 2003 : 18 : 939 942.
38. Frerichs RR, Srinivasan SR, Webber LS, Berenson GR. Serum cholesterol and triglyceride levels in 3,446 children from a biracial community: The Bogalusa Heart Study. Circulation 1976 : 54 : 302 309.
39. Ost L. Impairment of prednisolone metabolism by cyclosporine treatment in renal graft recipients. Transplantation 1987 : 44 : 533 535.
40. Lopez-Miranda J, Vilella E, Perez-Jiminez F, et al. Low-density lipoprotein metabolism in rats treated with cyclosporine. Metabolism 1993 : 42 : 678 683.
41. Apanay DC, Neylan JF, Ragab MS, Sgoutas DS. Cyclosporine increases the oxidizability of low-density lipoproteins in renal transplant recipients. Transplantation 1994 : 58 : 663 669.
42. Emeson EE, Shen ML. Accelerated atherosclerosis in hyperlipidemic C57BL/6 mice treated with cyclosporin A. Am J Pathol 1993 : 142 : 1906 1915.
43. Pascual J, Van Hoof JP, Salmela K, Lang P, Rigotti P, Budde K. Three-year observational follow-up of a multicenter, randomized trial on tacrolimus-based therapy with withdrawal of steroids or mycophenolate mofetil after renal transplant. Transplantation 2006 : 82 : 55 61.
44. Oberholzer J, John E, Lumpaopong A, et al. Early discontinuation of steroids is safe and effective in pediatric kidney transplant recipients. Pediatr Transplant 2005 : 9 : 456 463.
45. Sarwal MM, Yorgin PD, Alexander S, et al. Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation. Transplantation 2001 : 72 : 13 21.
46. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 2004 : 291 : 2847 2850.
47. Freedman DS, Dietz WH, Srinivasan SR, Berenson GS. The relation of overweight to cardiovascular risk factors among children and adolescents: The Bogalusa Heart Study. Pediatrics 1999 : 103 : 1175 1182.
48. Rodriguez BL, Fujimoto WY, Mayer-Davis EJ, et al. Prevalence of cardiovascular disease risk factors in U.S. children and adolescents with diabetes: The SEARCH for diabetes in youth study. Diabetes Care 2006 : 29 : 1891 1896.
49. Jago R, Harrell JS, Mcmurray RG, Edelstein S, El Ghormli L, Bassin S. Prevalence of abnormal lipid and blood pressure values among an ethnically diverse population of eighth-grade adolescents and screening implications. Pediatrics 2006 : 117 : 2065 2073.
50. Butani L. Prospective monitoring of lipid profiles in children receiving pravastatin preemptively after renal transplantation. Pediatr Transplant 2005 : 9 : 746 753.